Clinical Trial Results:
Etude multicentrique randomisée ouverte comparant la réduction virale et la tolérance
de l’association IFN alpha-2b XL + ribavirine versus IFN peg alpha-2b + ribavirine chez des
patients atteints d’hépatite chronique C de génotype 1
Summary
|
|
EudraCT number |
2009-015121-37 |
Trial protocol |
FR |
Global completion date |
26 Jun 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Apr 2022
|
First version publication date |
02 Apr 2022
|
Other versions |
|
Summary report(s) |
Summary of Final report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.